Research Grants from the National Multiple Sclerosis Society support investigators pursuing MS research to stop disease activity, restore function by reversing damage and symptoms, and prevent new cases.
Funder: National Multiple Sclerosis Society
Due Dates (Anticipated): February 2027 (Application deadline, anticipated)
Funding Amounts: Award budget and project length are set in each funding announcement
Summary: Supports investigator-initiated research to stop MS disease activity, restore function, and prevent new cases.
Key Information: The Society plans a separate targeted early detection and diagnosis RFA instead of investigator-initiated grants for the 2026–2027 winter cycle.
The National Multiple Sclerosis Society’s Research Grants program supports investigator-initiated studies addressing questions in the Pathways to MS Cures Roadmap. Its three pathways seek to stop MS disease activity, restore function by reversing damage and symptoms, and end MS by preventing new cases. Supported work includes fundamental and applied research, nonclinical and clinical studies, and projects in patient management, care, and rehabilitation.
The Society values collaboration across disciplines, sharing data and resources, and research involving underserved and understudied ethnic and racial MS populations. For the 2026–2027 winter cycle, it plans a separate targeted request for applications focused on early detection and diagnosis, aligned with its FY27–30 Strategic Plan. Investigator-initiated research remains part of its strategy, with future support approaches to be determined.